Mettler-Toledo International (NYSE:MTD) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Mettler-Toledo International (NYSE:MTD) had its price objective increased by analysts at Robert W. Baird from $1,362.00 to $1,369.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird’s price target suggests a potential downside of 1.51% from the stock’s previous close.

MTD has been the topic of several other research reports. Wolfe Research assumed coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their price target for the company from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Stifel Nicolaus lowered their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $1,358.63.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,390.00 on Monday. The stock has a market cap of $29.33 billion, a PE ratio of 34.30, a P/E/G ratio of 4.80 and a beta of 1.13. The firm has a 50-day moving average of $1,278.92 and a 200-day moving average of $1,343.25. Mettler-Toledo International has a 52-week low of $1,133.46 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 564.51% and a net margin of 22.29%. As a group, analysts predict that Mettler-Toledo International will post 41.94 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now owns 6 shares in the company, valued at $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several hedge funds have recently bought and sold shares of MTD. Sanctuary Advisors LLC bought a new position in shares of Mettler-Toledo International in the second quarter valued at $500,000. Wedmont Private Capital acquired a new stake in shares of Mettler-Toledo International in the 3rd quarter worth about $246,000. Livforsakringsbolaget Skandia Omsesidigt lifted its position in Mettler-Toledo International by 400.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 125 shares of the medical instruments supplier’s stock valued at $187,000 after acquiring an additional 100 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in Mettler-Toledo International by 2,300.0% during the 3rd quarter. Exchange Traded Concepts LLC now owns 144 shares of the medical instruments supplier’s stock valued at $216,000 after purchasing an additional 138 shares during the last quarter. Finally, Koshinski Asset Management Inc. increased its holdings in Mettler-Toledo International by 40.0% during the 3rd quarter. Koshinski Asset Management Inc. now owns 322 shares of the medical instruments supplier’s stock worth $483,000 after purchasing an additional 92 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.